Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Randy Dotinga

    News

    New coalition aims to revolutionize stalled lupus research

    Author:
    Randy Dotinga
    Publish date: March 30, 2023

    Public-private consortium plans to develop new approaches to clinical studies.

    • Read More

    News

    B-cell cancers: Sparse insight into preventing infections

    Author:
    Randy Dotinga
    Publish date: March 28, 2023

    Doctors treating CLL and other B-cell cancers are blindsided by a lack of research into acquired hypogammaglobulinemia prophylactics.

    • Read More

    News

    CLL and surgery are more compatible than ever

    Author:
    Randy Dotinga
    Publish date: March 20, 2023

    As patients fare better with targeted therapy, physicians say they can tolerate more procedures.

    • Read More

    News

    Plant-based diet linked to better outcomes in prostate cancer

    Author:
    Randy Dotinga
    Publish date: March 16, 2023

    Men who consumed more fruits and vegetables had slower cancer progression and lower risk of recurrence.

    • Read More

    News

    Inclusive reminder: LGBTQ community may donate stem cells

    Author:
    Randy Dotinga
    Publish date: March 8, 2023

    Advocates seek to reach donors who wrongly assumed that they were restricted from joining registries.

    • Read More

    News

    CLL treatment: More infections among real-world patients

    Author:
    Randy Dotinga
    Publish date: March 6, 2023

    Among real-world blood cancer patients treated with three drugs, study finds higher infection rates than in clinical trials.

    • Read More

    News

    Postpartum urinary retention: Intermittent catheterization may be best

    Author:
    Randy Dotinga
    Publish date: February 22, 2023

    Patients recovered more quickly when they were catheterized every 6 hours instead of for 24 continuous hours.

    • Read More

    News

    ‘Financial toxicity’ from breast cancer is a worldwide phenomenon

    Author:
    Randy Dotinga
    Publish date: February 21, 2023

    It’s highest in less-developed countries, with about a third of patients affected in the U.S.

    • Read More

    News

    Surviving CLL: Higher risk of other cancer DXs

    Author:
    Randy Dotinga
    Publish date: February 17, 2023

    A 30-year Dutch population study highlights the medical challenges facing patients with CLL, who are now living longer.

    • Read More

    News

    NICU use up, birth weights down in babies of mothers with HCV

    Author:
    Randy Dotinga
    Publish date: February 13, 2023

    New findings surprised a study researcher since the adverse outcomes weren’t related to prematurity.

    • Read More

    News

    More evidence suggests oxytocin can be discontinued early in labor

    Author:
    Randy Dotinga
    Publish date: February 10, 2023

    Withdrawal of medication between 4 and 6 cm of dilation doesn’t appear to affect neonatal outcomes.

    • Read More

    News

    Gene test may offer insights into treatment response in advanced NSCLC

    Author:
    Randy Dotinga
    Publish date: February 7, 2023

    Researchers linked positive assay results to longer progression-free survival.

    • Read More

    News

    Long-course radiation therapy better at organ-sparing in rectal cancer than short-term therapy

    Author:
    Randy Dotinga
    Publish date: February 7, 2023

    Patients who underwent short-course therapy had worse organ-preservation outcomes.

    • Read More

    News

    Immunotherapy with antibiotics doesn’t worsen biliary tract cancer outcomes

    Author:
    Randy Dotinga
    Publish date: February 6, 2023

    Previous studies and clinical observations have suggested that antibiotics during immunotherapy treatment may hasten negative outcomes.

    • Read More

    News

    Despite limits, COVID vaccines protect CLL patients

    Author:
    Randy Dotinga
    Publish date: February 6, 2023

    A small German study found that, in patients with CLL, COVID-19 shots don’t boost B cells but they do strengthen T cells.

    • Read More

    Pages

    • « first
    • …
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery